Scott, I., P. VanVeldhuisen, M. Ip, B. Blodi, N. Oden, C. Awh, D. Kunimoto, D. Marcus, J. Wroblewski, and J. King. Effect of Bevacizumab Vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial. JAMA, 2017, p. Epub PubMed Text.
Abstract
Importance: Studies have established the efficacy and safety of aflibercept for the treatment of macular edema due to central retinal vein occlusion. Bevacizumab is used off-label to treat this condition despite the absence of supporting data.